InBody Co

InBody Co Financing Cash Flow

The Net Financing Cash Flow of InBody Co (041830.KQ) as of Oct 25, 2026 is -15.11 B KRW. In the previous year, Net Financing Cash Flow was -6.16 B KRW — a change of 145.20% (lower).

Financing Cash Flow

-15.11 BKRW

YoY

145.20%

Last updated:

Net Financing Cash Flow of InBody Co is 2024 -15.11 B KRW. Net Financing Cash Flow of InBody Co was 2023 -6.16 B KRW. It decreases by 145.20% lower compared to the previous year.

The InBody Co Financing Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financing Cash Flow
Date
Financing Cash Flow
Jan 1, 2017
-4.21 B KRW
Jan 1, 2018
-1.65 B KRW
Jan 1, 2019
-7.42 B KRW
Jan 1, 2020
-9.18 B KRW
Jan 1, 2021
-4.27 B KRW
Jan 1, 2022
-5.25 B KRW
Jan 1, 2023
-6.16 B KRW
Jan 1, 2024
-15.11 B KRW
The InBody Co Financing Cash Flow history
YEARFinancing Cash FlowYoY
-15.11 BKRW+145.20%
-6.16 BKRW+17.31%
-5.25 BKRW+23.12%
-4.27 BKRW-53.51%
-9.18 BKRW+23.64%
-7.42 BKRW+349.61%
-1.65 BKRW-60.83%
-4.21 BKRW+287.01%
-1.09 BKRW+33.33%
-816.76 MKRW+57.61%
-518.22 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

InBody Co Stock analysis

What does InBody Co do? InBody Co., Ltd. generates revenue through the sale of body composition analyzers under the InBody and Lookin’Body brand names. The InBody series includes models such as InBody720, InBody520, InBody230, InBody R20, InBody S20, InBody S10, and InBody J10, while the Lookin’Body series offers Lookin’Body3.0 and Lookin’Body Basic for measuring proteins, minerals, fats, and moisture. The company also sells BMI measuring devices under the BSM brand. Products are distributed domestically and internationally to meet demand in both markets. The primary customers for InBody’s equipment are healthcare facilities, fitness centers, and wellness providers seeking accurate body composition data. The InBody series targets professional and clinical settings, whereas Lookin’Body products cater to general wellness and fitness applications. BSM devices serve as complementary tools for body mass index tracking in similar environments. InBody Co., Ltd. focuses on selling medical equipment directly to end-users and distributors, with no mention of third-party partnerships or additional revenue streams. The company’s product portfolio is designed to address diverse needs within the health and fitness industry, leveraging its established brand names for market penetration. InBody Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about InBody Co stock

Net Financing Cash Flow of InBody Co is -15.11 B KRW in 2024.

Net Financing Cash Flow of InBody Co changed from -6.16 B KRW to -15.11 B KRW, representing a 145.20% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Financing Cash Flow InBody Co since 2006 – with annual values, charts, and detailed analysis.

Financing cash flow measures cash flows from debt issuance/repayment, equity transactions, and dividend payments.

Net Financing Cash Flow's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Financing Cash Flow's InBody Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — InBody Co

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — InBody Co